Testing effectiveness (Phase 2)Not Yet RecruitingNCT07514455
What this trial is testing
Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients
Who this might be right for
Carcinoma, HepatocellularHepatic InsufficienDisease Progression+1 more
Ju Hyun Shim 20